Simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and their role in survival
- PMID: 35949610
- PMCID: PMC9353869
- DOI: 10.3892/ol.2022.13433
Simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and their role in survival
Abstract
Pulmonary carcinoid tumors are rare, low-grade malignant tumors that constitute 1-2% of all lung tumors. The present study aimed to describe the simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and determine their association with survival rates. For this purpose, 108 patients with resected carcinoid lung tumors were followed-up for 96 months and analyzed for simultaneous pathological findings in biopsy specimens. Among these, simultaneous pathological findings were found in 82 patients. The association between these findings and patient survival rates was evaluated. Atelectasis was a simultaneous finding in 52.4% of the patients, desquamative interstitial pneumonia (DIP) in 13.4%, emphysema in 24.4% and bronchiectasis in 9.8%. The survival rate was 100% for the patients with atelectasis, 81.8% for the patients with DIP, 90% for the patients with emphysema and 75% for the patients with bronchiectasis (P<0.05). According to the univariate analysis, the type of carcinoid was associated with patient survival with better survival rates for patients with typical carcinoids, while age, sex, stage and simultaneous pathological findings were not associated with patient survival. On the whole, there was a statistically significant difference in the survival rates of patients with resected lung carcinoids with different simultaneous pathological findings. However, further studies are warranted to assess the role of these findings in the survival of these patients.
Keywords: atelectasis; bronchiectasis; desquamative interstitial pneumonia; emphysema; lung carcinoids; neuroendocrine tumors.
Copyright: © Georgakopoulou et al.
Conflict of interest statement
DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have no competing interests.
Figures





Similar articles
-
Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center.Cureus. 2020 Sep 7;12(9):e10300. doi: 10.7759/cureus.10300. Cureus. 2020. PMID: 32923302 Free PMC article.
-
Prognostic value of the immunohistochemistry markers CD56, TTF-1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors.Mol Clin Oncol. 2022 Feb;16(2):31. doi: 10.3892/mco.2021.2464. Epub 2021 Dec 14. Mol Clin Oncol. 2022. PMID: 34984102 Free PMC article.
-
[Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].Acta Med Port. 2014 Nov-Dec;27(6):749-54. Epub 2014 Dec 30. Acta Med Port. 2014. PMID: 25641291 Portuguese.
-
Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.Biochim Biophys Acta. 2012 Dec;1826(2):255-71. doi: 10.1016/j.bbcan.2012.05.001. Epub 2012 May 10. Biochim Biophys Acta. 2012. PMID: 22579738 Review.
-
[Bronchopulmonary carcinoid tumours].Minerva Chir. 2002 Aug;57(4):403-23. Minerva Chir. 2002. PMID: 12145571 Review. Italian.
References
-
- Fraser RS, Muller NL, Colman N, Pare PD. Neuroendocrine neoplasms. 4th edition. Philadelphia: WB Saunders Co; 1999. Fraser and Pare's diagnosis of diseases of the chest; pp. 1229–1250.
-
- Colby TV, Koss M, Travis WD. Tumors of the lower respiratory tract. Armed Forces Institute of Pathology; Washington, DC: 1995. Atlas of tumor pathology.
LinkOut - more resources
Full Text Sources